Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 240-245
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.240
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.240
Subgroup | n | Periportal necrosis | Portal inflammation | Lobular necrosis | Fibrosis | Bile duct proliferation |
Sham only | 5 | 0.00 ± 0.00 | 0.40 ± 0.55 | 1.00 ± 1.22 | 0.00 ± 0.001 | 0.00 ± 0.001 |
Sham and phlebotomy later | 4 | 0.00 ± 0.00 | 1.25 ± 1.26 | 0.25 ± 0.50 | 0.00 ± 0.00 | 0.00 ± 0.00 |
Phlebotomy and sham later | 6 | 0.00 ± 0.00 | 1.00 ± 0.00 | 0.50 ± 0.55 | 0.67 ± 0.52 | 0.00 ± 0.00 |
BDL only | 9 | 0.89 ± 1.27 | 1.33 ± 1.00 | 2.11 ± 1.83 | 2.89 ± 0.78 | 2.67 ± 0.50 |
BDL and phlebotomy later | 8 | 0.13 ± 0.35 | 1.00 ± 0.00 | 3.00 ± 1.85 | 2.75 ± 0.71 | 2.88 ± 0.35 |
Phlebotomy and BDL later | 8 | 2.17 ± 1.33 | 2.67 ± 0.82 | 4.00 ± 0.00 | 3.33 ± 0.52 | 2.83 ± 0.41 |
- Citation: Peretz G, Link G, Pappo O, Bruck R, Ackerman Z. Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease. World J Gastroenterol 2006; 12(2): 240-245
- URL: https://www.wjgnet.com/1007-9327/full/v12/i2/240.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.240